Implementation of zero or near-zero fluoroscopy catheter ablation for idiopathic ventricular arrhythmia originating

Katarzyna Styczkiewicz1, Bartosz Ludwik2, Marek Styczkiewicz3

  • 1Department of Internal Medicine, Institute of Medical Sciences, Medical College, University of Rzeszów, Al. mjr.W.Kopisto 2a, 35-310, Rzeszów, Poland. krachwal@interia.pl.

Insights

Zero-fluoroscopy radiofrequency ablation (RFA) for idiopathic ventricular arrhythmias (IVAs) from the aortic sinus cusp (ASC) is feasible and safe. With experience, this zero-fluoroscopy approach becomes preferred, showing similar outcomes to near-zero fluoroscopy methods.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Technology

Background:

  • Radiofrequency ablation (RFA) is a standard treatment for idiopathic ventricular arrhythmias (IVAs).
  • Achieving zero-fluoroscopy (ZF) RFA for arrhythmias originating from the aortic sinus cusp (ASC) presents challenges.
  • Near-zero fluoroscopy (NOX) using 3D electroanatomic mapping (3D-EAM) is an alternative approach.

Purpose of the Study:

  • To evaluate the feasibility, safety, and learning curve of a zero-fluoroscopy (ZF) approach for RFA in patients with idiopathic ventricular arrhythmias originating from the aortic sinus cusp (IVA-ASC).
  • To compare the outcomes of ZF RFA with the near-zero fluoroscopy (NOX) approach in IVA-ASC.

Main Methods:

  • Retrospective analysis of 104 patients with IVA-ASC undergoing RFA between 2012 and 2018.
  • Utilized a 3-dimensional electroanatomic (3D-EAM) system (Ensite, Velocity, Abbott, USA).
  • Assessed acute, short-term, and long-term outcomes, including success rates, complications, procedure time, and fluoroscopy time.

Main Results:

  • ZF RFA was successfully completed in 83% of attempted cases (62/75), with 13 cases converted to NOX.
  • NOX approach achieved 100% completion (32/32).
  • No significant differences in success rates or major complications were observed between ZF and NOX.
  • Median procedure time was shorter for ZF (65.0 min) compared to NOX.
  • Fluoroscopy time was significantly reduced in the ZF group (0.0 min) versus NOX (0-5 min).
  • Preference for ZF increased from 43% in 2012-2016 to 98% in 2017-2018, correlating with reduced procedure times.

Conclusions:

  • Zero-fluoroscopy RFA is a feasible and safe option for IVA-ASC, particularly for operators experienced in the NOX approach.
  • With adequate training and experience, the ZF approach becomes the preferred technique.
  • 3D-EAM guided ZF ablation demonstrates comparable feasibility, safety, and effectiveness to the NOX approach for IVA-ASC.

Related Concept Videos